Literature DB >> 17056295

The role of transforming growth factor-beta in atherosclerosis.

Nishi N Singh1, Dipak P Ramji.   

Abstract

Transforming growth factor-beta (TGF-beta) plays a pivotal role in a range of biological processes, including the control of cellular proliferation and differentiation, regulation of tissue repair and extracellular matrix accumulation, and modulation of the immune and inflammatory responses. The role of TGF-beta in the pathogenesis of atherosclerosis, which is widely perceived as a form of chronic inflammation, has been the subject of debate for a number of years. A pro-atherogenic role was suspected because of its ability to promote fibrosis and to inhibit endothelial regeneration. However, several recent studies have shown that TGF-beta limits atherosclerosis by modulating a number of processes, including the accumulation of lipids in the vessel wall and the inflammatory response. This review will discuss the role of TGF-beta in atherosclerosis along with the molecular mechanisms underlying its action during the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056295     DOI: 10.1016/j.cytogfr.2006.09.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  36 in total

1.  Evaluation of resequencing on number of tag SNPs of 13 atherosclerosis-related genes in Thai population.

Authors:  Chintana Tocharoentanaphol; Somying Promso; Dianna Zelenika; Tassanee Lowhnoo; Sissades Tongsima; Thanyachai Sura; Wasun Chantratita; Fumihiko Matsuda; Sean Mooney; Anavaj Sakuntabhai
Journal:  J Hum Genet       Date:  2007-11-28       Impact factor: 3.172

Review 2.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 3.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

Review 4.  Role of somatic mutations in vascular disease formation.

Authors:  Sarah M Weakley; Jun Jiang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; F Charles Brunicardi; Richard A Gibbs; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2010-03       Impact factor: 5.225

5.  Renin-sensitive microRNAs correlate with atherosclerosis plaque progression.

Authors:  J Deiuliis; G Mihai; J Zhang; C Taslim; J J Varghese; A Maiseyeu; K Huang; S Rajagopalan
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

6.  Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.

Authors:  Ick-Mo Chung; Junwoo Kim; Youngmi K Pak; Yangsoo Jang; Woo-Ick Yang; Innoc Han; Seung-Jung Park; Seong-Wook Park; Jooryung Huh; Thomas N Wight; Hikaru Ueno
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

7.  IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14).

Authors:  Xinyuan Li; Ying Shao; Xiaojin Sha; Pu Fang; Yin-Ming Kuo; Andrew J Andrews; Yafeng Li; William Y Yang; Massimo Maddaloni; David W Pascual; Jin J Luo; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

Review 8.  Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.

Authors:  Lisa R Tannock; Victoria L King
Journal:  Rev Endocr Metab Disord       Date:  2008-06-27       Impact factor: 6.514

Review 9.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

10.  Genome-wide association studies of coronary artery disease and heart failure: where are we going?

Authors:  Gerald W Dorn; Sharon Cresci
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.